Overview
Background
Christine graduated with a Bachelor of Pharmacy degree (honours class 1) from the University of Queensland in 1996.
She registered as a pharmacist in Australia in 1997 and in the United Kingdom in 2003 and has worked at the Redlands, Princess Alexandra and Wesley Hospitals in Brisbane and the Western Infirmary in Glasgow. In 2002 she was awarded a PhD from the University of Queensland, with a thesis focusing on improving usage of the immunosuppressant agent tacrolimus in solid organ transplant recipients.
In 2004 she was the recipient of a National Health and Medical Research Council (NHMRC) Neil Hamilton Fairley fellowship. This award enabled her to training overseas in the field of Pharmacometrics within the Department of Medicine and Therapeutics at the University of Glasgow (Scotland) and the Department of Pharmaceutical Biosciences at Uppsala University (Sweden).
On her return to Brisbane, Christine was the recipient of a Lions Medical Research Fellowship and was the chief investigator on a three year NHMRC Project Grant. She has also been a team member on an Amgen-Transplant Society of Australia and New Zealand Research Grant and a Cellcept Australia Research Grant. Over her research career Christine has attracted grants and awards totaling more than 2 million AUD from various funding agencies.
Research Interests
Christine has a wide range of interests in the fields of Quality Use of Medicine and Pharmacometrics. Her work to date has primarily been directed towards optimising usage of immunosuppressant drugs in solid organ transplant recipients and antibiotics in patients with life-threatening infections.
Christine has published over 75 peer reviewed papers and 90 conference abstracts on these topics. Her publications have been cited on more than 3200 occasions, with twelve cited more than 50 times.
Christine has successfully supervised to completion fourteen higher research degree students and enjoys helping students meet their career goals.
Christine’s current projects include:
- Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
- Comparing the efficacy and safety of continuous versus intermittent administration of beta-lactams in critically ill patients
- Examining the relationship between immunosuppression and non-melanoma skin cancer in renal transplant recipients
- Improving individualisation of immunosuppressant therapy in adult kidney transplant recipients
- Improving gentamycin dosing in paediatric oncology patients
- Examining tobramycin monitoring in cystic fibrosis patients in Australia and the United Kingdom
- Investigating the relationship between prednisolone exposure and drug-related toxicity in paediatric and adult kidney transplant recipients
- Comparing different therapeutic drug monitoring methods for dosage adjustment of once daily intravenous tobramycin treatment in children with cystic fibrosis
Projects currently available for interested research higher degree students include:
- Dose optimisation of busulfan in paediatric bone marrow transplant recipients
- Investigating the relationship between immunosupressant exposure and drug-related toxicity in transplant recipients
- Examining Bayesian forecasting methods to predict immunosuppressant exposure
- Examining the international use of immunosuppressant and anti-rheumatic drugs
- Examining the influence of plasma exchange on immunosuppressant drug exposure
Christine invites potential honours and post-graduate students to contact her via email to discuss research opportunities.
Teaching interests
Co-ordinates:
- PHRM3052- Biological Fate of Drugs
Teaches in:
- PHRM3052- Biological Fate of Drugs
- PHRM3011- Quality Use of Medicines
Availability
- Dr Christine Staatz is:
- Available for supervision
Fields of research
Qualifications
- Bachelor, The University of Queensland
- Bachelor (Honours) of Pharmacy, The University of Queensland
- Doctor of Philosophy, The University of Queensland
Works
Search Professor Christine Staatz’s works on UQ eSpace
2001
Journal Article
Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants
Staatz, Christine E., Taylor, Paul J., Lynch, Stephen V., Willis, Charlene, Charles, Bruce G. and Tett, Susan E. (2001). Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants. Transplantation, 72 (6), 1056-1061. doi: 10.1097/00007890-200109270-00013
2001
Journal Article
Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation
Staatz, C, Taylor, P and Tett, S (2001). Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation. Nephrology Dialysis Transplantation, 16 (9), 1905-1909. doi: 10.1093/ndt/16.9.1905
2000
Journal Article
Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?
Collins, D., Coombes, J., Staatz, C. E., Stowasser, D. and Stowasser, M. (2000). Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?. Australian Journal of Hospital Pharmacy, 30 (2), 47-52.
2000
Journal Article
Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?
Stowasser, Danielle A., Staatz, Christine E., Stowasser, Michael, Coombes, Judith A. and Collins, David M. (2000). Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?. Australian Journal of Hospital Pharmacy, 30 (2), 47-53. doi: 10.1002/jppr200030247
2000
Conference Publication
Nonmen
Staatz, C. and Tett, S. E. (2000). Nonmen. Joint Meeting of ASCEPT and the British Pharmacological Society, Monash University, Melbourne, 25-28 April 2000. Australia: ASCEPT.
2000
Conference Publication
Bayesian forecasting to predict tacrolimus concentrations in paediatric liver transplant recipients
Willis, C., Staatz, C., Lynch, S. V. and Tett, S. E. (2000). Bayesian forecasting to predict tacrolimus concentrations in paediatric liver transplant recipients. Annual Scientific Meeting of ASCEPT 2000, Newcastle, NSW, Australia, 3-6 December, 2000. Lilydale, Vic.: ASCEPT.
1999
Conference Publication
Factors that influence the pharmacokinetics of Tacrolimus in paediatric liver transplant recipients
Staatz, C., Lynch, S. V., Taylor, P. J., Willis, C. and Tett, S. E (1999). Factors that influence the pharmacokinetics of Tacrolimus in paediatric liver transplant recipients. ASCEPT Conference, Sydney, N.S.W., December, 1999. Sydney: ASCEPT.
1999
Conference Publication
Population pharmacokinetics of tacrolimus in Australian paediatric and adult liver transplant recipients
Staatz, C., Taylor, P. J., Lynch, S. V., Charles, B. G. and Tett, S.E (1999). Population pharmacokinetics of tacrolimus in Australian paediatric and adult liver transplant recipients. 6th International Congress of IATDMCT, Cairns, Qld, 13-17 September, 1999. New York: Lippincott-Raven.
1998
Journal Article
Ester prodrugs of a potent analgesic, morphine-6-sulfate: syntheses, spectroscopic and physicochemical properties
PreechagoonD, BreretonI, Staatz, C and PrankerdR (1998). Ester prodrugs of a potent analgesic, morphine-6-sulfate: syntheses, spectroscopic and physicochemical properties. International Journal of Pharmaceutics, 163 (1-2), 177-190. doi: 10.1016/S0378-5173(97)00381-5
Funding
Current funding
Supervision
Availability
- Dr Christine Staatz is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Exploring free plasma tacrolimus and mycophenolic acid measurements and defining a therapeutic target range for therapeutic drug monitoring
Principal Advisor
Other advisors: Dr Meng-Wong Taing
-
Doctor Philosophy
Improving patient centred outcomes in kidney transplant recipients
Principal Advisor
Other advisors: Dr Andrew Mallett
-
Doctor Philosophy
To investigate the pharmacotherapy management of the bariatric surgery patient and the impact of the pharmacist in the multidisciplinary team
Associate Advisor
Other advisors: Dr Karen Whitfield
-
Doctor Philosophy
The IMPEDE-PKD Clinical Trial - Investigating the repurposing of metformin in ADPKD
Associate Advisor
Other advisors: Professor David Johnson, Professor Carmel Hawley, Dr Andrew Mallett, Associate Professor Andrea Viecelli
-
Doctor Philosophy
Establishing the Role of Metformin for Autosomal Dominant Polycystic Kidney Disease Management
Associate Advisor
Other advisors: Professor David Johnson, Professor Carmel Hawley, Associate Professor Andrea Viecelli, Dr Andrew Mallett
Completed supervision
-
2024
Doctor Philosophy
Improving patient centred outcomes in kidney transplant recipients
Principal Advisor
Other advisors: Dr Andrew Mallett
-
2023
Doctor Philosophy
Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Children: Once daily administration
Principal Advisor
-
2022
Doctor Philosophy
Optimising immunosuppressant medicines in elderly kidney transplant recipients
Principal Advisor
Other advisors: Associate Professor William Cottrell
-
2021
Doctor Philosophy
Evaluating Prediction Methods for Estimating Tacrolimus, Mycophenolate and Prednisolone Exposure Following Adult Kidney Transplantation
Principal Advisor
Other advisors: Emeritus Professor Sue Tett
-
2016
Doctor Philosophy
Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
Principal Advisor
Other advisors: Emeritus Professor Sue Tett
-
2016
Doctor Philosophy
Optimizing beta-lactam antibiotic dosing in critically ill patients: Prolonged infusion versus intermittent bolus administration
Associate Advisor
Other advisors: Professor Jeffrey Lipman, Professor Jason Roberts
-
2012
Doctor Philosophy
Pharmacokinetic, Pharmacogenetic and Pharmacodynamic Monitoring of Immunosuppressive Therapy in Adult Kidney Transplant Recipients
Associate Advisor
-
2018
Doctor Philosophy
Optimising gentamicin therapy in paediatric oncology patients
Joint Principal Advisor
-
2017
Doctor Philosophy
The impact of increasing patient weight on the dosing of high-dose methotrexate chemotherapy in aggressive non-Hodgkin lymphoma
Joint Principal Advisor
Media
Enquiries
For media enquiries about Dr Christine Staatz's areas of expertise, story ideas and help finding experts, contact our Media team: